
Eric Olson
Examiner (ID: 2127)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 1713 |
| Issued Applications | 963 |
| Pending Applications | 131 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7155972
[patent_doc_number] => 20050026877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Pharmaceutical compositions comprising active vitamin D compounds'
[patent_app_type] => utility
[patent_app_number] => 10/841954
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17233
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841954
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841954 | Pharmaceutical compositions comprising active vitamin D compounds | May 9, 2004 | Abandoned |
Array
(
[id] => 7318852
[patent_doc_number] => 20040224892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Oligosaccharides in cosmetic or dermatological compositions for stimulating adhesion of keratinocytes to major proteins of the dermoepidermal junction and restoration of epidermal cohesion'
[patent_app_type] => new
[patent_app_number] => 10/839420
[patent_app_country] => US
[patent_app_date] => 2004-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4136
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224892.pdf
[firstpage_image] =>[orig_patent_app_number] => 10839420
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/839420 | Oligosaccharides in cosmetic or dermatological compositions for stimulating adhesion of keratinocytes to major proteins of the dermoepidermal junction and restoration of epidermal cohesion | May 4, 2004 | Abandoned |
Array
(
[id] => 7191107
[patent_doc_number] => 20040204474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Carvedilol-lipophilic solutions'
[patent_app_type] => new
[patent_app_number] => 10/835137
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3390
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204474.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835137
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835137 | Carvedilol-lipophilic solutions | Apr 28, 2004 | Abandoned |
Array
(
[id] => 7466291
[patent_doc_number] => 20040198697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Compositions for the regulation of cytokine activity'
[patent_app_type] => new
[patent_app_number] => 10/831288
[patent_app_country] => US
[patent_app_date] => 2004-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 30697
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198697.pdf
[firstpage_image] =>[orig_patent_app_number] => 10831288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/831288 | Compositions for the regulation of cytokine activity | Apr 25, 2004 | Issued |
Array
(
[id] => 7379988
[patent_doc_number] => 20040220397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Solid support for the synthesis of 3\'-amino oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/830484
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14990
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220397.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830484 | Solid support for the synthesis of 3′-amino oligonucleotides | Apr 20, 2004 | Issued |
Array
(
[id] => 7061782
[patent_doc_number] => 20050004144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Combined use of IMPDH inhibitors with toll-like receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 10/824833
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 28962
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824833
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824833 | Combined use of IMPDH inhibitors with toll-like receptor agonists | Apr 13, 2004 | Abandoned |
Array
(
[id] => 7466263
[patent_doc_number] => 20040198693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Compounds for the treatment of ischemia'
[patent_app_type] => new
[patent_app_number] => 10/822411
[patent_app_country] => US
[patent_app_date] => 2004-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68999
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10822411
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/822411 | Compounds for the treatment of ischemia | Apr 11, 2004 | Abandoned |
Array
(
[id] => 7190314
[patent_doc_number] => 20040204383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Lysophosphatidic acid analogs and inhibition of neointima formation'
[patent_app_type] => new
[patent_app_number] => 10/821739
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8414
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204383.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821739
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821739 | Lysophosphatidic acid analogs and inhibition of neointima formation | Apr 8, 2004 | Abandoned |
Array
(
[id] => 5924245
[patent_doc_number] => 20060241101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds'
[patent_app_type] => utility
[patent_app_number] => 10/551821
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10325
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20060241101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551821 | Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds | Apr 1, 2004 | Abandoned |
Array
(
[id] => 914710
[patent_doc_number] => 07326734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-05
[patent_title] => 'Treatment of bladder and urinary tract cancers'
[patent_app_type] => utility
[patent_app_number] => 10/817449
[patent_app_country] => US
[patent_app_date] => 2004-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4421
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/326/07326734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10817449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/817449 | Treatment of bladder and urinary tract cancers | Mar 31, 2004 | Issued |
Array
(
[id] => 7346259
[patent_doc_number] => 20040192553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Inosine L-Arginine salt and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/808536
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3169
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808536
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808536 | Inosine L-Arginine salt and uses thereof | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7237692
[patent_doc_number] => 20050080024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Nitric oxide donating derivatives for the treatment of cardiovascular disorders'
[patent_app_type] => utility
[patent_app_number] => 10/807800
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28951
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807800 | Nitric oxide donating derivatives for the treatment of cardiovascular disorders | Mar 23, 2004 | Abandoned |
Array
(
[id] => 435921
[patent_doc_number] => 07262178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Treatment of sepsis and septic shock'
[patent_app_type] => utility
[patent_app_number] => 10/807961
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4249
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807961 | Treatment of sepsis and septic shock | Mar 23, 2004 | Issued |
Array
(
[id] => 5142695
[patent_doc_number] => 20070004911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Silylated oligonucleotide compounds'
[patent_app_type] => utility
[patent_app_number] => 10/550217
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6426
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004911.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550217 | Silylated oligonucleotide compounds | Mar 18, 2004 | Abandoned |
Array
(
[id] => 7316924
[patent_doc_number] => 20040224058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Maltitol solutions with high maltitol content and methods of making same'
[patent_app_type] => new
[patent_app_number] => 10/804502
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4978
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10804502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/804502 | Maltitol solutions with high maltitol content and methods of making same | Mar 18, 2004 | Abandoned |
Array
(
[id] => 42800
[patent_doc_number] => 07781408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Formulations for mediating inflammation and for reducing blood cholesterol'
[patent_app_type] => utility
[patent_app_number] => 10/551789
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 23378
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551789 | Formulations for mediating inflammation and for reducing blood cholesterol | Mar 11, 2004 | Issued |
Array
(
[id] => 7672927
[patent_doc_number] => 20040180852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus'
[patent_app_type] => new
[patent_app_number] => 10/796707
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13812
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10796707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/796707 | Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus | Mar 8, 2004 | Abandoned |
Array
(
[id] => 7977651
[patent_doc_number] => 08071572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Preventive/remedy for obesity'
[patent_app_type] => utility
[patent_app_number] => 10/547776
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547776
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547776 | Preventive/remedy for obesity | Mar 7, 2004 | Issued |
Array
(
[id] => 7319345
[patent_doc_number] => 20040225015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/793857
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11831
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20040225015.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793857
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793857 | Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient | Mar 7, 2004 | Issued |
Array
(
[id] => 7426664
[patent_doc_number] => 20040229824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Methods for using specific saccharides for treating Alzheimer\'s disease and other amyloidoses'
[patent_app_type] => new
[patent_app_number] => 10/793175
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11197
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793175 | Methods for using glucose pentasulfate for treating amyloid associated with type II diabetes | Mar 2, 2004 | Issued |